We are live on ! Find out more
MIM

Martin Investment Management Portfolio holdings

AUM $300M
1-Year Est. Return 6.05%
This Fund
S&P 500
This Quarter Est. Return
+7.28%
1 Year Est. Return
+6.05%
3 Year Est. Return
+44.71%
5 Year Est. Return
+50.94%
10 Year Est. Return
+276.43%
AUM
$398M
AUM Growth
+$13.9M
Cap. Flow
-$12.1M
Cap. Flow %
-3.05%
Top 10 Hldgs %
40.88%
Holding
47
New
5
Increased
14
Reduced
24
Closed
2

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$10.8M
2
TGT icon
Target
TGT
+$9.79M
3
CHKP icon
Check Point Software Technologies
CHKP
+$3.76M
4
SONY icon
Sony
SONY
+$2.98M
5
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$2.73M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$10.2M
2
MMM icon
3M
MMM
+$9.34M
3
MSCI icon
MSCI
MSCI
+$7.47M
4
MA icon
Mastercard
MA
+$3.05M
5
TMO icon
Thermo Fisher Scientific
TMO
+$2.29M

Sector Composition

Rank Sector Weight
1 Technology 21.9%
2 Financials 20.47%
3 Healthcare 17.71%
4 Industrials 10.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
26
Gilead Sciences
GILD
$165B
$9.13M 2.3%
135,184
-1,804
-1% -$119K
JNJ icon
27
Johnson & Johnson
JNJ
$625B
$8.89M 2.24%
63,853
-5,459
-8% -$756K
RTX icon
28
RTX Corp
RTX
$301B
$8.23M 2.07%
100,455
-13,853
-12% -$1.16M
TRV icon
29
Travelers Companies
TRV
$80.2B
$7.79M 1.96%
52,129
-7,492
-13% -$1.08M
GD icon
30
General Dynamics
GD
$106B
$7.47M 1.88%
41,074
-3,678
-8% -$633K
MPC icon
31
Marathon Petroleum
MPC
$83.7B
$5.94M 1.49%
106,221
-16,030
-13% -$877K
SONY icon
32
Sony
SONY
$138B
$5.03M 1.26%
480,200
+303,275
+171% +$2.98M
ALC icon
33
Alcon
ALC
$35B
$1.39M 0.35%
+22,434
New +$1.32M
GOOG icon
34
Alphabet (Google) Class C
GOOG
$4.32T
$1.04M 0.26%
19,340
-7,900
-29% -$456K
INFO
35
DELISTED
IHS Markit Ltd. Common Shares
INFO
$499K 0.13%
7,835
-365
-4% -$21K
KMB icon
36
Kimberly-Clark
KMB
$36.5B
$430K 0.11%
3,225
-210
-6% -$27.1K
MDT icon
37
Medtronic
MDT
$112B
$364K 0.09%
3,742
+80
+2% +$7.3K
ST icon
38
Sensata Technologies
ST
$6.79B
$321K 0.08%
6,549
+175
+3% +$8.33K
INTC icon
39
Intel
INTC
$513B
$298K 0.07%
6,227
– –
UL icon
40
Unilever
UL
$136B
$288K 0.07%
4,126
+102
+3% +$6.92K
MSFT icon
41
Microsoft
MSFT
$3.71T
$264K 0.07%
1,971
– –
V icon
42
Visa
V
$677B
$250K 0.06%
1,441
+16
+1% +$2.62K
TXN icon
43
Texas Instruments
TXN
$261B
$246K 0.06%
2,145
-65
-3% -$7.27K
RELX icon
44
RELX
RELX
$62B
$217K 0.05%
+8,875
New +$204K
FDS icon
45
Factset
FDS
$10.2B
$206K 0.05%
+720
New +$199K
MMM icon
46
3M
MMM
$94.3B
– –
-53,749
Closed -$9.34M
CELG
47
DELISTED
Celgene Corp
CELG
– –
-107,759
Closed -$10.2M
1
2

Similar funds

RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
KEM
Kimmeridge Energy Management New York $299M AUM 36.96% 1-Year Est. Return
I
InterCapital Austin, Texas $299M AUM
GB
Goepper Burkhardt Greenville, South Carolina $299M AUM 12.16% 1-Year Est. Return
UCB
United Community Bank Greenville, South Carolina $300M AUM 14.66% 1-Year Est. Return
RP
Riverwater Partners Milwaukee, Wisconsin $300M AUM 26.4% 1-Year Est. Return
SC
Sykon Capital Harrison, New York $300M AUM 16.74% 1-Year Est. Return
FPCG
Forum Private Client Group Fishers, Indiana $300M AUM 12.15% 1-Year Est. Return

Martin Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Martin Investment Management held 47 positions worth $398M, up 3.6% from $384M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Martin Investment Management withdrew a net $12.1M in Q2 2019, closing 2 positions and reducing 24 holdings. Its most notable exit was Celgene Corp, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Martin Investment Management opened a new position in Bristol-Myers Squibb worth $10.5M.

  • Martin Investment Management's largest Q2 2019 buy was Bristol-Myers Squibb: 232,069 shares worth $10.5M.
  • Martin Investment Management added most to Check Point Software Technologies in Q2 2019, an estimated $3.76M increase.
  • Martin Investment Management's biggest Q2 2019 reduction was MSCI, cutting an estimated $7.47M.
  • Martin Investment Management fully exited Celgene Corp in Q2 2019, selling an estimated $10.2M.
  • Martin Investment Management's ten largest holdings make up 41% of its $398M portfolio in Q2 2019.
  • Martin Investment Management opened 5 new positions and closed 2 in Q2 2019.
  • Martin Investment Management's portfolio value rose 3.6% quarter-over-quarter to $398M.

Based on Martin Investment Management's 13F filing for Q2 2019, filed 7 Aug 2019.